Canlyniadau Chwilio - Virley, David

Developing Therapeutics for the Treatment of Multiple Sclerosis gan Virley, David J.

Cael y testun llawn Cael y testun llawn

5-HT(6) receptor antagonists as novel cognitive enhancing agents for Alzheimer’s disease gan Upton, Neil, Chuang, Tsu Tshen, Hunter, Ann J., Virley, David J.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

The Neuroprotective Effect of a Specific P2X(7) Receptor Antagonist Derives from its Ability to Inhibit Assembly of the NLRP3 Inflammasome in Glial Cells gan Murphy, Niamh, Cowley, Thelma R., Richardson, Jill C., Virley, David, Upton, Neil, Walter, Daryl, Lynch, Marina A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Identification of an epidermal keratinocyte AMPA glutamate receptor involved in dermatopathies associated with sensory abnormalities gan Cabañero, David, Irie, Takeshi, Celorrio, Marta, Trousdale, Christopher, Owens, David M., Virley, David, Albrecht, Phillip J., Caterina, Michael J., Rice, Frank L., Morón, Jose A.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amy... gan Pugh, Perdita L, Vidgeon-Hart, Martin P, Ashmeade, Tracey, Culbert, Ainsley A, Seymour, Zoe, Perren, Marion J, Joyce, Flora, Bate, Simon T, Babin, Anna, Virley, David J, Richardson, Jill C, Upton, Neil, Sunter, David

Cael y testun llawn Cael y testun llawn Cael y testun llawn